Table 2.
Variables | Reference range | Patient group | P-value | Control group | P-value | ||
---|---|---|---|---|---|---|---|
Male (n=34) | Female (n=32) | Male (n=34) | Female (n=32) | ||||
Uric acid (mg/dl) | 3–7 | 4.35 (1.33) | 3.86 (1.19) | 0.1 | 3.40 (0.92) | 3.13 (1.18) | 0.3 |
Albumin (g/dl) | 3.5–5.5 | 4.58 (0.45) | 4.58 (0.41) | 0.9 | 4.69 (0.41) | 4.61 (0.42) | 0.5 |
Bilirubin (mg/dl) | 0–1 | 1.51 (0.98) | 0.98 (0.54) | 0.008** | 0.64 (0.42) | 0.70 (0.32) | 0.5 |
TAS (mmol/l) | 1.3–1.77 | 1.56 (0.18) | 1.44 (0.17) | 0.005** | 1.40 (0.22) | 1.31 (0.17) | 0.09 |
Ferritin (ng/ml) | 10–400 | 2121 (1623) | 2472 (1763) | 0.4 | - | - | - |
AST (u/l) | <40 | 29.50 (13.85) | 27.58 (17.63) | 0. 2 | - | - | - |
ALT (u/l) | <40 | 34.09 (15.78) | 33.34 (24.26) | 0. 2 | - | - | - |
TAS: Total antioxidant status, AST: Aspartate aminotransferase, ALT: Alanine aminotransferase
The data are given based on mean values (Standard Deviation)